Latest advancement in designing and evaluation of MDR inhibitors targeting P-glycoprotein / 国外医学(肿瘤学分册)
Journal of International Oncology
;
(6)2006.
Artículo
en Chino
| WPRIM
| ID: wpr-640381
ABSTRACT
Over-expression of P-glycoprotein (Pgp) is associated with the development of multi-drug resistance ( MDR). Pgp has been focused on as the main target in designing chemotherapy strategy. In this article we review some of the latest advancement in designing and evaluation methods of P- glycoprotein inhibitors.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of International Oncology
Año:
2006
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS